| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Daniel J. Moore | Q38325799 |
| Craig S. Nunemaker | Q57438288 | ||
| P2093 | author name string | Anthony L McCall | |
| Boris Kovatchev | |||
| Kenneth L Brayman | |||
| Xiaolun Huang | |||
| Robert J Ketchum | |||
| P2860 | cites work | Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse | Q24290693 |
| The autoimmune regulator (AIRE) is a DNA-binding protein | Q24291636 | ||
| ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells | Q24296273 | ||
| Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta | Q24311833 | ||
| A family of cytokine-inducible inhibitors of signalling | Q24313168 | ||
| The unique cytoarchitecture of human pancreatic islets has implications for islet cell function | Q24541464 | ||
| The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation | Q24654107 | ||
| Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome | Q24677071 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Positional cloning of the APECED gene | Q28116470 | ||
| The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein | Q28140689 | ||
| Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen | Q28141785 | ||
| Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents | Q28196845 | ||
| Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES) | Q28200186 | ||
| Toll-like receptors and acquired immunity | Q35642955 | ||
| Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus | Q35741943 | ||
| Hepatocyte growth factor gene therapy for islet transplantation | Q35753520 | ||
| Use of Sertoli cell transplants to provide local immunoprotection for tissue grafts | Q35790833 | ||
| Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review. | Q35803455 | ||
| Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo | Q35847438 | ||
| Islet transplantation in patients with diabetes mellitus: choice of immunosuppression | Q35891569 | ||
| Death effectors of beta-cell apoptosis in type 1 diabetes | Q35908961 | ||
| Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts | Q35928910 | ||
| Beta-cells in type 2 diabetes: a loss of function and mass | Q35946606 | ||
| Regulatory functions of CD8+CD28– T cells in an autoimmune disease model | Q36001202 | ||
| Methods of human islet culture for transplantation | Q36008369 | ||
| The role of the innate immunity in islet transplantation | Q36084955 | ||
| Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody | Q36263421 | ||
| How do CD4+CD25+ regulatory T cells control autoimmunity? | Q36279165 | ||
| Advances in pancreatic islet transplantation in humans | Q36347873 | ||
| Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice | Q36357636 | ||
| Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process | Q36363681 | ||
| Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening | Q36364959 | ||
| Continuous glucose monitoring and closed-loop systems | Q36367034 | ||
| Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. | Q36370525 | ||
| Physiological β Cell Death Triggers Priming of Self-reactive T Cells by Dendritic Cells in a Type-1 Diabetes Model | Q36371477 | ||
| Systemic exposure to irradiated apoptotic cells induces autoantibody production | Q36401434 | ||
| Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes | Q36455218 | ||
| Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets. | Q36458495 | ||
| Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state | Q36459935 | ||
| Current status of pancreatic islet transplantation. | Q36475429 | ||
| Developments in clinical islet, liver thoracic, kidney and pancreas transplantation in the last 5 years | Q36505718 | ||
| Interventional strategies to prevent beta-cell apoptosis in islet transplantation. | Q36521066 | ||
| Type 1 diabetes: pathogenesis and prevention | Q36538943 | ||
| Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction | Q36560836 | ||
| Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. | Q36603252 | ||
| Complexity of anti-immunosenescence strategies in humans | Q36616598 | ||
| Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation | Q28201202 | ||
| SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2 | Q28201656 | ||
| Aire deficient mice develop multiple features of APECED phenotype and show altered immune response | Q28202432 | ||
| Projection of an immunological self shadow within the thymus by the aire protein | Q28207164 | ||
| Pharmacological approaches to studying platelet function: an overview | Q28210863 | ||
| Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage | Q28214799 | ||
| Adenosine A2A receptor agonists as anti-inflammatory agents | Q28242079 | ||
| Islet transplantation as a treatment for diabetes - a work in progress | Q28244953 | ||
| The influence of age on T cell generation and TCR diversity | Q28251818 | ||
| Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX | Q28265206 | ||
| Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists | Q28354178 | ||
| Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells | Q28513895 | ||
| TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat | Q28571409 | ||
| Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+ interferon-gamma-induced apoptosis in primary pancreatic beta-cells | Q28574877 | ||
| Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus | Q28581226 | ||
| Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms | Q28586863 | ||
| Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling | Q28646137 | ||
| CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells | Q29618394 | ||
| X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy | Q29619109 | ||
| The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 | Q29619324 | ||
| A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
| Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection | Q30307082 | ||
| The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice | Q30309929 | ||
| Inhibition of STAT4 activation by lisofylline is associated with the protection of autoimmune diabetes | Q30312012 | ||
| Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction | Q30312207 | ||
| The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation | Q30312209 | ||
| Lisofylline, a novel anti-inflammatory agent, enhances glucose-stimulated insulin secretion in vivo and in vitro: studies in prediabetic and normal rats | Q30312217 | ||
| A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis | Q30433444 | ||
| Inflammation blockade improves pancreatic islet function | Q30435500 | ||
| A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells | Q30435569 | ||
| Inflammatory blockade improves human pancreatic islet function and viability | Q30435910 | ||
| Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes | Q30440311 | ||
| Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis | Q30441350 | ||
| Cloned receptors and cardiovascular responses to adenosine | Q30467649 | ||
| CD4+ CD25+ regulatory T-cells inhibit the islet innate immune response and promote islet engraftment | Q82984549 | ||
| Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes | Q82995443 | ||
| Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo | Q83059341 | ||
| Islets transplanted intraportally into the liver are stimulated to insulin and glucagon release exclusively through the hepatic artery | Q83149361 | ||
| A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity | Q83288981 | ||
| Ameliorating injury during preservation and isolation of human islets using the two-layer method with perfluorocarbon and UW solution | Q83829195 | ||
| Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects | Q83874715 | ||
| Proapoptotic Bax is hyperexpressed in isolated human islets compared with antiapoptotic Bcl-2. | Q44255124 | ||
| Survival and metabolic function of syngeneic rat islet grafts transplanted in the omental pouch | Q44339715 | ||
| Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells | Q44517194 | ||
| Thymic transplantation in miniature swine: III. Induction of tolerance by transplantation of composite thymokidneys across fully major histocompatibility complex-mismatched barriers | Q44552329 | ||
| Importance of hyperglycemia on the primary function of allogeneic islet transplants | Q44584364 | ||
| Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse. | Q44631808 | ||
| Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation | Q44662213 | ||
| Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? | Q44711155 | ||
| Intraportally transplanted pancreatic islets revascularized from hepatic arterial system | Q44763396 | ||
| Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. | Q44816724 | ||
| Increased NF-kappa B activity in B cells and bone marrow-derived dendritic cells from NOD mice | Q44870681 | ||
| Resistance to anti-CD45RB-induced tolerance in NOD mice: mechanisms involved | Q44892804 | ||
| Closing the loop: the adicol experience | Q44937934 | ||
| CD4+ T regulatory cell induction and function in transplant recipients after CD154 blockade is TLR4 independent | Q44988229 | ||
| NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance induction | Q45043581 | ||
| Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets | Q45071409 | ||
| Adenoviral overexpression of interleukin-1 receptor antagonist protein increases beta-cell replication in rat pancreatic islets | Q45172296 | ||
| Pharmacologically regulated regeneration of functional human pancreatic islets. | Q45178243 | ||
| {beta}-Cell function following human islet transplantation for type 1 diabetes | Q45199133 | ||
| The portal immunosuppressive storm: relevance to islet transplantation? | Q45234964 | ||
| Evaluation of intrathymic islet transplantation in the prediabetic period | Q45349099 | ||
| TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats | Q45532280 | ||
| The effect of cyclosporin-A, low-temperature culture, and anti-Ia antibodies on prevention of rejection of rat islet allografts | Q45794005 | ||
| Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction | Q45858530 | ||
| Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro | Q45862217 | ||
| Hepatocyte Growth Factor Gene Therapy for Pancreatic Islets in Diabetes: Reducing the Minimal Islet Transplant Mass Required in a Glucocorticoid-Free Rat Model of Allogeneic Portal Vein Islet Transplantation | Q45869446 | ||
| Prevention of beta cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I. | Q45874299 | ||
| Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoy | Q45876325 | ||
| Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice | Q45883411 | ||
| Lisofylline, an inhibitor of unsaturated phosphatidic acid generation, ameliorates interleukin-1 beta-induced dysfunction in cultured rat islets | Q46215526 | ||
| Purified murine islet allografts: islet engraftment as influenced by implantation site and glucotoxicity. | Q46297668 | ||
| Destruction of islet isografts by severe nonspecific inflammation | Q46377623 | ||
| Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts | Q46475231 | ||
| Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice. | Q46478181 | ||
| Targeted inactivation of hepatocyte growth factor receptor c-met in beta-cells leads to defective insulin secretion and GLUT-2 downregulation without alteration of beta-cell mass | Q46570550 | ||
| Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes. | Q46608639 | ||
| Regulation of pancreatic beta-cell mass and proliferation by SOCS-3. | Q46745814 | ||
| Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes | Q46774731 | ||
| Intra-ductal glutamine administration reduces oxidative injury during human pancreatic islet isolation. | Q46816085 | ||
| Natural killer T-cells participate in rejection of islet allografts in the liver of mice | Q46870163 | ||
| Long-term acceptance of fully allogeneic cardiac grafts by cotransplantation of vascularized thymus in miniature swine | Q46900304 | ||
| NOD macrophages produce high levels of inflammatory cytokines upon encounter of apoptotic or necrotic cells | Q47241689 | ||
| Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity | Q47265853 | ||
| Distinct maturation of, but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases | Q47310051 | ||
| Size-dependent revascularization of transplanted pancreatic islets | Q47336429 | ||
| Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets | Q47690560 | ||
| Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction. | Q47725489 | ||
| B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. | Q47757360 | ||
| Putative environmental factors in Type 1 diabetes. | Q48030340 | ||
| Activation of Macrophage-Associated Molecules after Brain Death in Islets | Q48336546 | ||
| Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy | Q30853783 | ||
| Activation of SOCS-3 by resistin | Q30856129 | ||
| Low revascularization of experimentally transplanted human pancreatic islets | Q30872883 | ||
| Androgen receptors in thymic epithelium modulate thymus size and thymocyte development | Q31957984 | ||
| Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection | Q33187036 | ||
| Five-year follow-up after clinical islet transplantation | Q33218078 | ||
| Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells | Q33624770 | ||
| Limited effect of CpG ODN in preventing type 1 diabetes in NOD mice | Q33628140 | ||
| HLA-mismatched renal transplantation without maintenance immunosuppression | Q33640791 | ||
| How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex | Q33797139 | ||
| Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes? | Q33806397 | ||
| A(2A) adenosine receptors in human peripheral blood cells | Q33849871 | ||
| Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand | Q33853062 | ||
| Intercellular adhesion molecule 1 is induced on isolated endocrine islet cells by cytokines but not by reovirus infection | Q33868162 | ||
| Natural adjuvants: endogenous activators of dendritic cells | Q33878894 | ||
| Grafts of supplementary thymuses injected with allogeneic pancreatic islets protect nonobese diabetic mice against diabetes | Q33894591 | ||
| Further studies on the transplantation of isolated pancreatic islets | Q34044682 | ||
| Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes | Q34091887 | ||
| Inhibition of ICAM-1/LFA-1 interactions prevents B-cell-dependent anti-CD45RB-induced transplantation tolerance | Q34107796 | ||
| Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity | Q34109834 | ||
| Tolerance to islet autoantigens in type 1 diabetes | Q34178116 | ||
| Revascularization and microcirculation of freely grafted islets of Langerhans | Q34245839 | ||
| Innate immunity and inflammation: a transcriptional paradigm | Q34303215 | ||
| Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis. | Q34360402 | ||
| A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1 | Q34388164 | ||
| Pancreatic islet transplantation for diabetes: successes, limitations, and challenges for the future | Q34396192 | ||
| Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. | Q34487172 | ||
| A choice of death--the signal-transduction of immune-mediated beta-cell apoptosis | Q34495385 | ||
| Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions | Q34527799 | ||
| Toll-like receptors in systemic autoimmune disease | Q34576448 | ||
| Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents. | Q34596884 | ||
| Microchimerism in autoimmunity and transplantation: potential relevance to multiple sclerosis | Q34646812 | ||
| Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis | Q34719541 | ||
| "Infectious" transplantation tolerance. | Q34726892 | ||
| Regulation of regulatory T cells: role of dendritic cells and toll-like receptors | Q36638378 | ||
| Role of autoantibodies in type 1 diabetes | Q36664712 | ||
| Cooperation of Toll-like receptor signals in innate immune defence | Q36743540 | ||
| Islet vasculature as a regulator of endocrine pancreas function | Q36755457 | ||
| Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. | Q36766872 | ||
| CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects | Q36826059 | ||
| Glucolipotoxicity: fuel excess and beta-cell dysfunction. | Q36861036 | ||
| The impact of insulin resistance on endothelial function, progenitor cells and repair | Q36892494 | ||
| Progress toward antibody-induced transplantation tolerance | Q36921578 | ||
| Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells | Q36937316 | ||
| Type 1 diabetes as a relapsing-remitting disease? | Q36992950 | ||
| Cytokines and beta-cell biology: from concept to clinical translation | Q37019667 | ||
| Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial | Q37055003 | ||
| The role of sex steroids and gonadectomy in the control of thymic involution. | Q37092435 | ||
| Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction | Q37332163 | ||
| Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients | Q37356987 | ||
| TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes | Q37358159 | ||
| Type 1 IFN mediates cross-talk between innate and adaptive immunity that abrogates transplantation tolerance | Q37494764 | ||
| TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts | Q37562436 | ||
| SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice | Q38295719 | ||
| IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death | Q38303234 | ||
| Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection | Q38310308 | ||
| Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance | Q40135934 | ||
| Functional MR microimaging of pancreatic beta-cell activation | Q40276558 | ||
| Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation | Q40328896 | ||
| Exposure to chronic high glucose induces beta-cell apoptosis through decreased interaction of glucokinase with mitochondria: downregulation of glucokinase in pancreatic beta-cells | Q40381260 | ||
| Cell-based immunotherapy with suppressor CD8+ T cells in rheumatoid arthritis | Q40419753 | ||
| Baculovirus p35 increases pancreatic beta-cell resistance to apoptosis | Q40421895 | ||
| Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. | Q40452210 | ||
| The role of innate immunity in autoimmunity. | Q40459661 | ||
| Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}. | Q40477727 | ||
| The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade | Q40624980 | ||
| Insulin dependent diabetes mellitus in the non-obese diabetic mouse: a disease mediated by T cell anergy? | Q40636843 | ||
| Non-genetic risk determinants of type 1 diabetes | Q40655935 | ||
| Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. | Q40673661 | ||
| Target cell defense prevents the development of diabetes after viral infection. | Q40741831 | ||
| The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. | Q40816941 | ||
| Dominant negative MyD88 proteins inhibit interleukin-1beta /interferon-gamma -mediated induction of nuclear factor kappa B-dependent nitrite production and apoptosis in beta cells | Q40857756 | ||
| Glucose toxicity: the implications of hyperglycemia in the pathophysiology of diabetes mellitus. | Q40939499 | ||
| Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells | Q40991239 | ||
| Prevention of diabetes in BB/Wor rats by intrathymic islet injection | Q41018994 | ||
| Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function | Q41020720 | ||
| Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. | Q41151273 | ||
| Hematopoietic cell transplantation for the induction of allo- and xenotolerance. | Q41180145 | ||
| Allotransplantation of culture-isolated neonatal rat islet tissue. Absence of MHC class II positive antigen-presenting cells in nonimmunogenic islets | Q41259986 | ||
| A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus | Q41291146 | ||
| In Vivo Imaging of Immune Rejection in Transplanted Pancreatic Islets | Q60192350 | ||
| A defect in bone marrow derived dendritic cell maturation in the nonobesediabetic mouse | Q60739111 | ||
| Evidence from Transgenic Mice That Interferon-β May Be Involved in the Onset of Diabetes Mellitus | Q60937528 | ||
| Cutting Edge: Anti-CD154 Therapeutic Antibodies Induce Infectious Transplantation Tolerance | Q61651670 | ||
| Cytokine profile and insulin antibody IgG subclasses in patients with recent onset Type 1 diabetes treated with oral insulin | Q63348373 | ||
| Changes in Inflammatory Cytokines Are Related to Impaired Glucose Tolerance in Offspring of Type 2 Diabetic Subjects | Q64355576 | ||
| Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice | Q67589807 | ||
| Intrathymic Islet Transplantation in the Spontaneously Diabetic BB Rat | Q67904500 | ||
| Pretransplantation blood transfusion revisited | Q68016806 | ||
| Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth | Q68143697 | ||
| Induction of donor-specific unresponsiveness by intrathymic islet transplantation | Q68354945 | ||
| Transplantation of intact pancreatic islets in rats | Q68495876 | ||
| Transplantation of isolated pancreatic islets across strong and weak histocompatibility barriers | Q68506774 | ||
| Glucose toxicity | Q68519957 | ||
| Immunostimulation circumvents diabetes in NOD/Lt mice | Q69313715 | ||
| Effect of cyclosporine and low-temperature culture on prevention of rejection of islet xenografts (rat-to-mouse) | Q70286871 | ||
| Gamma interferon induces novel expression of Ia antigens by rat pancreatic islet endocrine cells | Q70356955 | ||
| NOD marrow stem cells adoptively transfer diabetes to resistant (NOD x NON)F1 mice | Q70395198 | ||
| A new site for islet transplantation--a peritoneal-omental pouch | Q70443079 | ||
| Prolongation of rat islet allograft survival by direct ultraviolet irradiation of the graft | Q70464374 | ||
| Pancreatic islet transplantation: immuno-alteration with ultraviolet irradiation | Q70482507 | ||
| Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans | Q70530953 | ||
| Bone marrow abnormalities in the non-obese diabetic mouse | Q70608733 | ||
| Adenosine enhances IL-10 secretion by human monocytes | Q71151729 | ||
| New perspectives on the microvasculature of the islets of Langerhans in the rat | Q71470083 | ||
| Spontaneous diabetes in rats: destruction of islets is prevented by immunological tolerance | Q71565180 | ||
| Prolongation of islet xenograft survival by in vitro culture of rat megaislets in 95% O2 | Q71612293 | ||
| Interferon expression in the pancreases of patients with type I diabetes | Q71698025 | ||
| Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes | Q71699810 | ||
| Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1- and Th2-type infiltrates | Q71811771 | ||
| Prevention of spontaneous autoimmune diabetes in diabetes-prone BB rats by prophylactic treatment with antirat interferon-gamma antibody | Q71930600 | ||
| Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice | Q71968128 | ||
| Survival of heart allografts in nonimmunosuppressed murine recipients by pretreatment of the donor tissue with anti-Ia antibodies | Q72063085 | ||
| Deletion of donor-reactive T lymphocytes in adult mice after intrathymic inoculation with lymphoid cells | Q72216469 | ||
| Protective effect of preservation of canine pancreas by the two-layer (University of Wisconsin solution/perfluorochemical) method against rewarming ischemic injury during implantation | Q72322224 | ||
| The failure of intrathymic transplantation of nonimmunogenic islet allografts to promote induction of donor-specific unresponsiveness | Q72354324 | ||
| Prevention of diabetes and insulitis by neonatal intrathymic islet administration in NOD mice | Q72495233 | ||
| Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion | Q72580976 | ||
| Prolongation of rat islet allografts with the use of ultraviolet irradiation, without immunosuppression | Q72816659 | ||
| Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved | Q73026029 | ||
| Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment | Q73034296 | ||
| Processing and presentation of the islet autoantigen GAD by vascular endothelial cells promotes transmigration of autoreactive T-cells | Q73048880 | ||
| Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naïve phenotypes | Q73066946 | ||
| Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity | Q73209258 | ||
| Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice | Q73289663 | ||
| Islet isolation and transplantation outcomes of pancreas preserved with University of Wisconsin solution versus two-layer method using preoxygenated perfluorocarbon | Q48356065 | ||
| Metabolic mechanisms of failure of intraportally transplanted pancreatic beta-cells in rats: role of lipotoxicity and prevention by leptin. | Q50691879 | ||
| The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression. | Q51483620 | ||
| Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. | Q51500191 | ||
| Heightened interferon-alpha/beta response causes myeloid cell dysfunction and promotes T1D pathogenesis in NOD mice. | Q51775394 | ||
| [Significance of the size of islands of Langerhans for successful vascularization after free transplantation] | Q51833263 | ||
| Stimulation by glucose of the blood flow to the pancreatic islets of the rat | Q51853114 | ||
| Toll-dependent control mechanisms of CD4 T cell activation. | Q51996404 | ||
| A role for TGFbeta and B cells in immunologic tolerance after intravenous injection of soluble antigen. | Q52017514 | ||
| Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. | Q52022038 | ||
| Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. | Q52172385 | ||
| Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. | Q52226171 | ||
| Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? | Q52536571 | ||
| SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes. | Q52574322 | ||
| Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets. | Q52575906 | ||
| Augmented lipopolysaccharide-induced TNF-alpha production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK. | Q53579615 | ||
| Pancreatic islet production of vascular endothelial growth factor--a is essential for islet vascularization, revascularization, and function. | Q53591473 | ||
| Glucose ingestion induces an increase in intranuclear nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects. | Q53604416 | ||
| Improved human islet isolation using nicotinamide. | Q53612771 | ||
| Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility. | Q53626789 | ||
| Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection. | Q53627738 | ||
| Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway. | Q53650288 | ||
| Composite islet-endothelial cell grafts: a novel approach to counteract innate immunity in islet transplantation. | Q53654471 | ||
| NOD B-cells are insufficient to incite T-cell-mediated anti-islet autoimmunity. | Q53668853 | ||
| Amelioration of diabetes in mice after single-donor islet transplantation using the controlled release of gelatinized FGF-2. | Q53729453 | ||
| CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes. | Q53846131 | ||
| Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. | Q53859655 | ||
| Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. | Q53875137 | ||
| IFN beta accelerates autoimmune type 1 diabetes in nonobese diabetic mice and breaks the tolerance to beta cells in nondiabetes-prone mice. | Q53879223 | ||
| Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. | Q53883439 | ||
| Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity. | Q53904936 | ||
| NF-kappa B hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages. | Q53941826 | ||
| International trial of the Edmonton protocol for islet transplantation. | Q54032399 | ||
| NOD mice have a generalized defect in their response to transplantation tolerance induction. | Q54095945 | ||
| Both CD4(+)and CD8(+)T cells are required for IFN-gamma gene expression in pancreatic islets and autoimmune diabetes development in biobreeding rats. | Q54104308 | ||
| Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. | Q54154251 | ||
| Priming with donor spleen cells and activated B cells can induce prolonged survival of class I-disparate skin allografts in cyclophosphamide-treated mice | Q54162391 | ||
| Intrathymic transplantation of islet antigen affects CD8+ diabetogenic T-cells resulting in tolerance to autoimmune IDDM. | Q54166748 | ||
| Drug-induced tolerance to allografts in mice. X. Augmentation of split tolerance in murine combinations disparate at both H-2 and non-H-2 antigens by the use of spleen cells from donors preimmunized with recipient antigens. | Q54407631 | ||
| Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. | Q54453992 | ||
| Association between microchimerism and multiple sclerosis in Canadian twins. | Q54592056 | ||
| Characteristics of rat CD4(+)CD25(+) T cells and their ability to prevent not only diabetes but also insulitis in an adoptive transfer model in BB rats | Q56902065 | ||
| Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion | Q56904126 | ||
| Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells | Q56909439 | ||
| Role of Blood Glucose in Cytokine Gene Expression in Early Syngeneic Islet Transplantation | Q57160908 | ||
| The Type 1 Diabetes Locus Idd6 Controls TLR1 Expression | Q57632620 | ||
| Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors | Q57731080 | ||
| Angiotensin II Type 1 Receptor Blockade Improves Hyperglycemia-Induced Endothelial Dysfunction and Reduces Proinflammatory Cytokine Release From Leukocytes | Q57790233 | ||
| Thymic transplantation in miniature swine. I. Development and function of the "thymokidney" | Q73299809 | ||
| Primary nonfunction of islet xenografts in rat recipients results from non-T-cell-mediated immune responses | Q73321620 | ||
| Thymic transplantation in miniature swine. II. Induction of tolerance by transplantation of composite thymokidneys to thymectomized recipients | Q73520553 | ||
| Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival? | Q73581826 | ||
| Exocrine contamination of isolated islets of Langerhans deteriorates the process of revascularization after free transplantation | Q73648733 | ||
| Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide | Q73688337 | ||
| Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens | Q73929105 | ||
| Survival and function of syngeneic rat islet grafts placed within the thymus versus under the kidney capsule | Q74083380 | ||
| Role of macrophages and natural killer cells in the rejection of pig islet xenografts in mice | Q74147280 | ||
| Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic beta cells to tumor necrosis factor | Q74181605 | ||
| Dendritic cells from nonobese diabetic mice exhibit a defect in NF-kappa B regulation due to a hyperactive I kappa B kinase | Q74244221 | ||
| Contribution of ecto-5'-nucleotidase to the inhibition of platelet aggregation by human endothelial cells | Q74296189 | ||
| Intrathymic kidney cells delay the onset of lupus nephritis in MRL-lpr/lpr mice | Q74535813 | ||
| Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice | Q74601824 | ||
| Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo | Q75224515 | ||
| gamma-Interferon signaling in pancreatic beta-cells is persistent but can be terminated by overexpression of suppressor of cytokine signaling-1 | Q77292209 | ||
| Adoptively transferable tolerance induced by CD45RB monoclonal antibody | Q77361906 | ||
| Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function | Q77483789 | ||
| Linked suppression of skin graft rejection can operate through indirect recognition | Q77620004 | ||
| Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes | Q77658697 | ||
| The potential contribution of rejection to survival of transplanted human islets | Q77683727 | ||
| Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 | ||
| Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition | Q77719695 | ||
| Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis | Q77751091 | ||
| Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose | Q77795060 | ||
| Vascularized thymic lobe transplantation in miniature swine: I. Vascularized thymic lobe allografts support thymopoiesis | Q77801806 | ||
| Cellular and molecular changes accompanying the progression from insulitis to diabetes | Q77952302 | ||
| I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice | Q77967366 | ||
| Decreased vascular density in mouse pancreatic islets after transplantation | Q78014687 | ||
| Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides | Q78229544 | ||
| CD25+ immunoregulatory CD4 T cells mediate acquired central transplantation tolerance | Q78701766 | ||
| Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation | Q78724482 | ||
| Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells | Q78806915 | ||
| Examination of gene expression profile of functional human pancreatic islets after 2-week culture | Q79439038 | ||
| Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients | Q79455744 | ||
| Postprandial hyperglycemia alters inflammatory and hemostatic parameters | Q79999725 | ||
| Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation | Q80172749 | ||
| TLR engagement prevents transplantation tolerance | Q80256970 | ||
| Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes | Q80257287 | ||
| Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis | Q80353010 | ||
| Procurement of the human pancreas for pancreatic islet transplantation | Q80465083 | ||
| Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+ CD4 T cells | Q80736006 | ||
| Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes | Q80813712 | ||
| MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo | Q81008990 | ||
| CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation | Q81406391 | ||
| Would blockage of cytokines improve the outcome of pancreatic islet transplantation? | Q81459802 | ||
| Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells | Q82097325 | ||
| Graft vascular function after transplantation of pancreatic islets | Q34728192 | ||
| Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets | Q34796756 | ||
| Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo | Q35059150 | ||
| Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection | Q35073626 | ||
| Severe pancreatitis with exocrine destruction and increased islet neogenesis in mice with suppressor of cytokine signaling-1 deficiency. | Q35103140 | ||
| The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. | Q35132147 | ||
| Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. | Q35165534 | ||
| Regulatory CD4+CD25+T cells in prevention of allograft rejection | Q35212916 | ||
| Reduction of inflammation by decreasing production of interleukin-1 or by specific receptor antagonism | Q35382135 | ||
| Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants | Q35467756 | ||
| Involvement of growth factors in thymic involution | Q35591810 | ||
| Islet cell autoimmunity and transplantation tolerance: two distinct mechanisms? | Q35609267 | ||
| NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice | Q35629489 | ||
| Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression | Q35632241 | ||
| The role of donor lymphoid cells in the transfer of allograft tolerance | Q41370391 | ||
| Immunogenetics and the cause of autoimmune disease | Q41578264 | ||
| The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes | Q41731978 | ||
| Valpha14 NK T cell-triggered IFN-gamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets. | Q41788479 | ||
| Defects in the differentiation and function of bone marrow-derived dendritic cells in non-obese diabetic mice | Q41852796 | ||
| Interleukin 10 is a growth factor for a population of regulatory T cells | Q42224716 | ||
| Macrophage-mediated cytotoxicity against cultured pancreatic islet cells. | Q42455600 | ||
| Pseudoislet vascularization. Induction of diaphragm-fenestrated endothelia from the hepatic sinusoids | Q42486707 | ||
| Glucose-induced [Ca2+]i abnormalities in human pancreatic islets: important role of overstimulation | Q42495919 | ||
| Implantation site-dependent dysfunction of transplanted pancreatic islets | Q42510464 | ||
| Feasibility of automating insulin delivery for the treatment of type 1 diabetes | Q42604696 | ||
| Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol | Q43456511 | ||
| Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms | Q43508044 | ||
| Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition | Q43623084 | ||
| Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function | Q43829924 | ||
| Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation | Q43833546 | ||
| Insulin gene transfer enhances the function of human islet grafts. | Q43886282 | ||
| Intrathymic islet transplantation in the canine: I. Histological and functional evidence of autologous intrathymic islet engraftment and survival in pancreatectomized recipients | Q43940363 | ||
| Induction of angiogenesis by growth factors: relevance to pancreatic islet transplantation | Q43983826 | ||
| Effect of the two-layer (University of Wisconsin solution-perfluorochemical plus O2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol | Q44228612 | ||
| Control of B-cell responses by Toll-like receptors | Q59066168 | ||
| P433 | issue | 5 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 603-630 | |
| P577 | publication date | 2008-07-29 | |
| P1433 | published in | Endocrine Reviews | Q3054007 |
| P1476 | title | Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation | |
| P478 | volume | 29 |
| Q30432947 | A practical guide to rodent islet isolation and assessment |
| Q33604558 | Cellular production of n-3 PUFAs and reduction of n-6-to-n-3 ratios in the pancreatic beta-cells and islets enhance insulin secretion and confer protection against cytokine-induced cell death |
| Q34519401 | Creating transplant tolerance by taming adverse intragraft innate immunity |
| Q30430008 | Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation |
| Q42072077 | Delivery of a therapeutic protein by immune-privileged Sertoli cells |
| Q35568544 | Derivation of insulin producing cells from human endometrial stromal stem cells and use in the treatment of murine diabetes |
| Q42776160 | Effects of cyclooxygenase-2 inhibitor and adenosine triphosphate-sensitive potassium channel opener in syngeneic mouse islet transplantation |
| Q91455812 | Ethylene carbodiimide-fixed donor splenocytes combined with cordycepin induce long-term protection to mice cardiac allografts |
| Q48904983 | Ethylene carbodiimide-fixed donor splenocytes combined with α-1 antitrypsin induce indefinite donor-specific protection to mice cardiac allografts. |
| Q30430981 | Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling |
| Q30430239 | Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation |
| Q30875559 | Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic mice |
| Q36258142 | Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice |
| Q37149186 | Human pancreatic islets and diabetes research |
| Q50856415 | Human α1-antitrypsin modifies B-lymphocyte responses during allograft transplantation. |
| Q28748969 | In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes |
| Q53393573 | Islet culture and counter-culture. Commentary on: Effect of short-term culture on functional and stress-related parameters in isolated human islets by Ihm et al. |
| Q48058086 | Low energy X-ray (grenz ray) treatment of purified islets prior to allotransplant markedly decreases passenger leukocyte populations |
| Q30415616 | Naturally occurring immunoglobulin M (nIgM) autoantibodies prevent autoimmune diabetes and mitigate inflammation after transplantation |
| Q36576134 | Regulatory properties of the intestinal microbiome effecting the development and treatment of diabetes |
| Q30743822 | Residual β-Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation |
| Q44188868 | Selective depletion of alloreactive T cells leads to long-term islet allograft survival across a major histocompatibility complex mismatch in diabetic mice. |
| Q26823294 | Stem cell therapy to cure type 1 diabetes: from hype to hope |
| Q34152418 | TNF-α acutely upregulates amylin expression in murine pancreatic beta cells |
| Q57177826 | The Flaws and Future of Islet Volume Measurements |
| Q46360637 | The effects of digestion enzymes on islet viability and cellular composition |
| Q30409961 | The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation |
| Q46025705 | The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro. |
| Q27013927 | Use of glucagon-like peptide-1 agonists to improve islet graft performance |
| Q34977998 | β-Cell inflammation in human type 2 diabetes and the role of autophagy. |
Search more.